The 340B Drug Pricing Program plays a pivotal role in ensuring affordable healthcare by offering substantial discounts on outpatient medications to eligible healthcare providers. Since its establishment in 1992, the program has transformed how healthcare organizations manage drug costs, enabling them to reinvest savings into critical services. This blog delves into the mechanics of 340B pricing, its financial impact on covered entities, and its broader implications for the healthcare system.
Read More: https://340bwell.com/blogs/340B-Pricing-Insights-into-Discounts-and-Fin…